Cite

    Elnassery, N. et al. (2016). The impact of using gonadotropin-releasing hormone agonist for triggering final oocyte maturation in antagonist-treated intracytoplasmic sperm injection cycles on women at high risk of developing ovarian hyperstimulation syndrome. Evidence based women's health journal. 6 (3), p. . [Online].